Showing results (181-190 of 299) with videos related to

Sort By:
Pageof 30
Stress (Amsterdam, Netherlands)|July 18, 2015
Stressful life events and incident metabolic syndrome: the Hoorn studyFemke Rutters, Stefan Pilz, Anitra D M Koopman, et al.
European Journal of Cancer Care|December 31, 2013
Real-world resource use and costs of adjuvant treatment for stage III colon cancerC W M van Gils, S de Groot, S S Tan, et al.
Surgical Oncology|October 7, 2011
Quality of life, functional ability and physical activity after different surgical interventions for bone cancer of the leg: A systematic reviewW Peter Bekkering, Theodora P M Vliet Vlieland, Marta Fiocco, et al.
Virchows Archiv : an International Journal of Pathology|February 21, 2015
Mitochondrial microsatellite instability in patients with metastatic colorectal cancerS Venderbosch, S van Vliet, M H C Craenmehr, et al.
Journal of Surgical Oncology|July 19, 2012
Translation and preliminary validation of the English version of the DUX questionnaire for lower extremity bone tumor patients (Bt-DUX): a disease-specific measure for quality of lifeW Peter Bekkering, Laura Billing, Rob J Grimer, et al.
Pediatric Blood & Cancer|February 8, 2011
Health-related quality of life after completion of successful treatment for childhood cancerV Engelen, H M Koopman, S B Detmar, et al.
BMJ (Clinical Research Ed.)|February 6, 1998
Compression ultrasonography for diagnostic management of patients with clinically suspected deep vein thrombosis: prospective cohort studyA Cogo, A W Lensing, M M Koopman, et al.
Metabolism: Clinical and Experimental|March 12, 2019
The association between GAD65 antibody levels and incident Type 2 Diabetes Mellitus in an adult population: A meta-analysisAnitra D M Koopman, Joline W Beulens, Ellis Voerman, et al.
The European Respiratory Journal|August 20, 2011
Rapid early weight gain is associated with wheeze and reduced lung function in childhoodA C van der Gugten, M Koopman, A M V Evelein, et al.
British Journal of Cancer|September 18, 2008
GSTP1 Ile105Val polymorphism correlates with progression-free survival in MCRC patients treated with or without irinotecan: a study of the Dutch Colorectal Cancer GroupD M Kweekel, M Koopman, N F Antonini, et al.
Pageof 30